Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 121,433 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Atrial Fibrillation, Atrial Flutter
Interventions: beta blockers, amiodarone, ascorbic acid; Drug
Lead sponsor: MaineHealth; Other
Eligibility: 18 Years and older
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Portland, Maine

Conditions: HIV/AIDS
Interventions: PrEP Education and option to accept a PrEP prescription; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Persistent Concussion Symptoms
Interventions: Subthreshold exercise (STEP) with mobile health coaching, Light stretching (LS); Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 11 Years to 18 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Ultrasound Therapy; Complications, Cardiac Device Implant, Venous Access
Interventions: Ultrasound guided venous access, Conventional technique; Procedure
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: HIV
Interventions: Cognitive Behavioral Therapy techniques; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer
Interventions: capecitabine, lapatinib; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 5
States / cities: Basking Ridge, New Jersey • Commack, New York • New York, New York + 2 more

Conditions: Multiple Myeloma
Interventions: Ixazomib, Lenalidomide, Dexamethasone; Drug
Lead sponsor: Millennium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 20
States / cities: Berkeley, California • Duarte, California • Stanford, California + 15 more

Conditions: Vaginitis
Interventions: BDMax Vaginal Panel; Diagnostic Test
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 299 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Sleep Apnea
Interventions: Health coaching; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Melanoma
Interventions: observational; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: PROM
Interventions: Misoprostol, Oxytocin; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Unresectable Stage III, Stage IV Melanoma
Interventions: Lenvatinib; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 79
States / cities: Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 76 more

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Kuvan, Multivitamin; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 64 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Cancer, Immune-related Adverse Event
Interventions: Medical chart review; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Arthroplasty, Replacement, Knee
Interventions: Not listed
Lead sponsor: Colorado Joint Replacement; Other
Eligibility: Not listed
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Systemic Lupus Erythematosus
Interventions: Belimumab plus Early Vaccination, Belimumab plus Late Vaccination; Biological
Lead sponsor: Human Genome Sciences Inc., a GSK Company; Industry
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 15
States / cities: Birmingham, Alabama • Paradise Valley, Arizona • Shreveport, Louisiana + 11 more

Conditions: Vision Loss Partial, Hemianopia, Hemianopia Homonymous, Quadrantanopia, Stroke, Ischemic
Interventions: Training in the Blind Field, Training in the Sighted Field; Other
Lead sponsor: University of Rochester; Other
Eligibility: 17 Years to 75 Years
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2024
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Metabolic Syndrome
Interventions: Berberine, Identical Placebo; Dietary Supplement · Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Kaposi's Sarcoma
Interventions: Maraviroc; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Autism, Cognition Disorder
Interventions: Donepezil hydrochloride, Increase REM sleep percentage; Drug · Behavioral
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 2 Years to 10 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Knee Osteoarthritis
Interventions: DA/MI Intervention, an educational program (an NIH-developed booklet); Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 50 Years and older
Enrollment: 493 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Lymphoma
Interventions: bleomycin sulfate, filgrastim, cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, leucovorin calcium, methotrexate, prednisone, trimethoprim-sulfamethoxazole, vincristine sulfate, radiation therapy, Intrathecal cytarabine; Biological · Drug · Radiation
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 2011
U.S. locations: 85
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 53 more

Conditions: Infection, Human Immunodeficiency Virus
Interventions: DTG, CBZ; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Fall
Interventions: Balance Exercises - Smartphone Delivery, Balance Exercises - Traditional Paper Delivery; Device · Other
Lead sponsor: Binghamton University; Other
Eligibility: 65 Years to 90 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Binghamton, New York

Search by objective public record fields.

Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery

Packaging PrEP to Prevent HIV Among WWID

Study of an Exercise Program (STEP) for Youth With Concussion

Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation

Addressing Discrimination and Mistrust Among Black Men: Phase III

Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Diagnostic Accuracy By Providers Study

Health Coaching for Positive Airway Pressure Adherence

Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma

Pitocin or Oral Misoprostol for PROM IOL

An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma

Kuvan in People With Schizophrenia and Schizoaffective Disorder

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

Early Clinical Results of Mobile-Bearing Revision Total Knee Arthroplasty

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage

Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism

Race and Preference for Knee Replacement: A Patient-Centered Intervention

SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma

Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects

Use of a Smartphone to Assess Balance and Provide Intervention to Older Adults at Home